WallStreetZenWallStreetZen

NASDAQ: TNGX
Tango Therapeutics Inc Stock

$3.40+0.21 (+6.58%)
Updated Jun 5, 2023
TNGX Price
$3.40
Fair Value Price
$3.87
Market Cap
$300.58M
52 Week Low
$2.47
52 Week High
$8.56
P/E
-2.7x
P/B
1.32x
P/S
14.01x
PEG
N/A
Dividend Yield
N/A
Revenue
$24.87M
Earnings
-$110.98M
Gross Margin
100%
Operating Margin
-446.04%
Profit Margin
-446.3%
Debt to Equity
0.78
Operating Cash Flow
-$114M
Beta
1.17
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

TNGX Overview

Tango Therapeutics Incorporated is a biotechnology company that develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 to treat cancers with methylthioadenosine phosphorylase deletions. The company is also developing Ubiquitin-specific protease 1, an inhibitor to treat patients with BRCA1 or BRCA2-mutant cancers, and Target 3 for STK11-mutant cancers. Tango Therapeutics was founded in 2017 and is headquartered in Cambridge, MA.

Zen Score

Industry Average (26)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how TNGX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

TNGX ($3.40) is undervalued by 12.21% relative to our estimate of its Fair Value price of $3.87 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
TNGX ($3.40) is not significantly undervalued (12.21%) relative to our estimate of its Fair Value price of $3.87 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
TNGX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more TNGX due diligence checks available for Premium users.

Be the first to know about important TNGX news, forecast changes, insider trades & much more!

TNGX News

Valuation

TNGX fair value

Fair Value of TNGX stock based on Discounted Cash Flow (DCF)
Price
$3.40
Fair Value
$3.87
Undervalued by
12.21%
TNGX ($3.40) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
TNGX ($3.40) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
TNGX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

TNGX price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-2.7x
Industry
11.59x
Market
53.21x

TNGX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.32x
Industry
5.21x
TNGX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

TNGX's financial health

Profit margin

Revenue
$5.8M
Net Income
-$28.0M
Profit Margin
-485.7%
TNGX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
TNGX's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$403.8M
Liabilities
$176.5M
Debt to equity
0.78
TNGX's short-term assets ($343.00M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
TNGX's short-term assets ($343.00M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
TNGX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$34.9M
Investing
$31.6M
Financing
$73.0k
TNGX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

TNGX vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
TNGX$300.58M+6.58%-2.70x1.32x
STRO$301.48M+5.72%-2.10x1.63x
ATAI$302.14M+3.41%-1.90x1.28x
FHTX$304.07M+2.39%-2.69x-12.37x
DSGN$308.26M-4.34%-4.41x0.99x

Tango Therapeutics Stock FAQ

What is Tango Therapeutics's quote symbol?

(NASDAQ: TNGX) Tango Therapeutics trades on the NASDAQ under the ticker symbol TNGX. Tango Therapeutics stock quotes can also be displayed as NASDAQ: TNGX.

If you're new to stock investing, here's how to buy Tango Therapeutics stock.

What is the 52 week high and low for Tango Therapeutics (NASDAQ: TNGX)?

(NASDAQ: TNGX) Tango Therapeutics's 52-week high was $8.56, and its 52-week low was $2.47. It is currently -60.27% from its 52-week high and 37.65% from its 52-week low.

How much is Tango Therapeutics stock worth today?

(NASDAQ: TNGX) Tango Therapeutics currently has 88,406,523 outstanding shares. With Tango Therapeutics stock trading at $3.40 per share, the total value of Tango Therapeutics stock (market capitalization) is $300.58M.

Tango Therapeutics stock was originally listed at a price of $10.23 in Sep 3, 2020. If you had invested in Tango Therapeutics stock at $10.23, your return over the last 2 years would have been -66.76%, for an annualized return of -42.35% (not including any dividends or dividend reinvestments).

How much is Tango Therapeutics's stock price per share?

(NASDAQ: TNGX) Tango Therapeutics stock price per share is $3.40 today (as of Jun 5, 2023).

What is Tango Therapeutics's Market Cap?

(NASDAQ: TNGX) Tango Therapeutics's market cap is $300.58M, as of Jun 6, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Tango Therapeutics's market cap is calculated by multiplying TNGX's current stock price of $3.40 by TNGX's total outstanding shares of 88,406,523.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.